New Vernon Capital Holdings Ii LLC Pfizer Inc Transaction History

New Vernon Capital Holdings Ii LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $21,348 - $27,728	-817 Reduced 8.96%	8,298 $238,000
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $44,573 - $52,101	1,389 Added 17.98%	9,115 $302,000
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $123,349 - $142,712	3,415 Added 79.22%	7,726 $283,000
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $177,061 - $231,134	4,241 Added 6058.57%	4,311 $220,000
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $3,063 - $3,739	70 New	70 $3,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of New Vernon Capital Holdings Ii LLC, based on Form 13F filings with the SEC.

Stay updated on New Vernon Capital Holdings Ii LLC with notifications on news.